Texas Gov't Awards Mirna $5M Grant; Firm Aims to File Two INDs in 2011 | GenomeWeb

By Doug Macron

Mirna Therapeutics this week announced that it has received a $5 million funding commitment from Texas through the state's Emerging Technology Fund, which the state government established to help companies develop new technologies.

The ETF award, $2.5 million of which Mirna has already received, "is a catalyst for advancing our microRNA mimic-discovery platform and a robust pipeline of promising drug candidates” Mirna President and CEO Paul Lammers said in a statement.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.